Anthony J. Polverino Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Anthony J. Polverino.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Anthony J. Polverino. Anthony J. Polverino is Director in BRAINSTORM CELL THERAPEUTICS INC. ($BCLI) and Chief Scientific Officer in Zymeworks Inc. ($ZYME).
Latest Insider Trading Transactions of Anthony J. Polverino
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 12 2021 | ZYME | Zymeworks Inc. | Polverino Anthony J. | Chief Scientific Of ... | Option Exercise | A | 0.00 | 8,125 | 0 | 8,125 | |
| Mar 12 2021 | ZYME | Zymeworks Inc. | Polverino Anthony J. | Chief Scientific Of ... | Option Exercise | A | 34.82 | 48,750 | 1,697,475 | 48,750 | |
| Mar 12 2021 | ZYME | Zymeworks Inc. | Polverino Anthony J. | Chief Scientific Of ... | Option Exercise | M | 0.00 | 2,500 | 0 | 5,000 | |
| Mar 12 2021 | ZYME | Zymeworks Inc. | Polverino Anthony J. | Chief Scientific Of ... | Sell | S | 34.95 | 1,048 | 36,631 | 30,979 | 32 K to 31 K (-3.27 %) |
| Mar 12 2021 | ZYME | Zymeworks Inc. | Polverino Anthony J. | Chief Scientific Of ... | Buy | M | 0.00 | 2,500 | 0 | 32,027 | 29.5 K to 32 K (+8.47 %) |
| Jan 11 2021 | ZYME | Zymeworks Inc. | Polverino Anthony J. | Chief Scientific Of ... | Grant | A | 30.92 | 48 | 1,484 | 29,527 | 29.5 K to 29.5 K (+0.16 %) |
| Jul 06 2020 | ZYME | Zymeworks Inc. | Polverino Anthony J. | Chief Scientific Of ... | Grant | A | 30.66 | 488 | 14,962 | 29,479 | 29 K to 29.5 K (+1.68 %) |
| Mar 11 2020 | ZYME | Zymeworks Inc. | Polverino Anthony J. | Chief Scientific Of ... | Option Exercise | A | 0.00 | 7,500 | 0 | 7,500 | |
| Mar 11 2020 | ZYME | Zymeworks Inc. | Polverino Anthony J. | Chief Scientific Of ... | Option Exercise | A | 35.20 | 45,000 | 1,584,000 | 45,000 | |
| Feb 14 2020 | BCLI | BRAINSTORM CELL TH ... | Polverino Anthony J. | Director | Grant | A | 0.00 | 3,071 | 0 | 15,862 | 12.8 K to 15.9 K (+24.01 %) |
| Feb 14 2020 | BCLI | BRAINSTORM CELL TH ... | Polverino Anthony J. | Director | Grant | A | 0.00 | 2,000 | 0 | 12,791 | 10.8 K to 12.8 K (+18.53 %) |
| Jan 09 2020 | ZYME | Zymeworks Inc. | Polverino Anthony J. | Chief Scientific Of ... | Grant | A | 19.54 | 371 | 7,249 | 28,991 | 28.6 K to 29 K (+1.30 %) |
| Dec 13 2019 | ZYME | Zymeworks Inc. | Polverino Anthony J. | Chief Scientific Of ... | Option Exercise | M | 15.00 | 27,500 | 412,500 | 82,500 | |
| Dec 13 2019 | ZYME | Zymeworks Inc. | Polverino Anthony J. | Chief Scientific Of ... | Buy | M | 15.00 | 27,500 | 412,500 | 28,620 | 1.1 K to 28.6 K (+2,455.36 %) |
| Jul 10 2019 | ZYME | Zymeworks Inc. | Polverino Anthony J. | Chief Scientific Of ... | Grant | A | 12.49 | 1,120 | 13,989 | 1,120 | 0 to 1.1 K |
| Feb 22 2019 | BCLI | BRAINSTORM CELL TH ... | Polverino Anthony J. | Director | Grant | A | 0.00 | 3,501 | 0 | 10,791 | 7.3 K to 10.8 K (+48.02 %) |
| Jan 10 2019 | ZYME | Zymeworks Inc. | Polverino Anthony J. | Chief Scientific Of ... | Option Exercise | A | 15.53 | 75,000 | 1,164,750 | 75,000 | |
| Nov 30 2018 | BCLI | BRAINSTORM CELL TH ... | Polverino Anthony J. | Director | Grant | A | 0.00 | 1,667 | 0 | 7,290 | 5.6 K to 7.3 K (+29.65 %) |
| Nov 30 2018 | BCLI | BRAINSTORM CELL TH ... | Polverino Anthony J. | Director | Grant | A | 0.00 | 2,000 | 0 | 5,623 | 3.6 K to 5.6 K (+55.20 %) |
| Feb 05 2018 | BCLI | BRAINSTORM CELL TH ... | Polverino Anthony J. | Director | Grant | A | 0.00 | 3,623 | 0 | 3,623 | 0 to 3.6 K |
Page: 1